KetoConference 2019 - Modern Genomics – Impact on the Management of Drug Resistant Epilepsy
Dr Alasdair Parker discusses how genetic testing may shape the future treatment for epilepsy.
Please log in to access this content
Simply log in or register to Nutricia Academy today to access this content as well as a host of other trusted education resources.
Speaker: Dr Alasdair Parker, Consultant Paediatric Neurologist, Addenbrookes Hospital, Cambridge
Genetics and How it may Shape Future Treatment for Epilepsy
You may also be interested in
Also on this website
About Nutricia
Follow us on LinkedIn
Follow us on Twitter
- Nutricia Limited is a company registered in England and Wales with company number 00275552. VAT Number GB436975115
- © 2023 Nutricia. All rights reserved.